Published in Transl Psychiatry on September 06, 2016
Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci U S A (2004) 17.86
A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry (1999) 13.56
Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci (1990) 8.61
Neurodevelopmental trajectories of the human cerebral cortex. J Neurosci (2008) 7.14
Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology (2004) 6.08
Three-dimensional magnetization-prepared rapid gradient-echo imaging (3D MP RAGE). Magn Reson Med (1990) 6.04
Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J Neurosci (2000) 6.02
Attention-deficit hyperactivity disorder. Lancet (2005) 5.75
Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward. Science (2010) 5.48
Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA (2002) 4.72
Transient neuronal inhibition reveals opposing roles of indirect and direct pathways in sensitization. Nat Neurosci (2010) 3.55
Causal models of attention-deficit/hyperactivity disorder: from common simple deficits to multiple developmental pathways. Biol Psychiatry (2005) 3.51
Distinct roles for direct and indirect pathway striatal neurons in reinforcement. Nat Neurosci (2012) 3.40
Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychol Bull (2011) 3.14
Longitudinal mapping of cortical thickness and clinical outcome in children and adolescents with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry (2006) 3.10
Distinct roles of synaptic transmission in direct and indirect striatal pathways to reward and aversive behavior. Neuron (2010) 3.10
Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry (1996) 3.05
The Laboratory Rat: Relating Its Age With Human's. Int J Prev Med (2013) 2.90
Mapping changes in the human cortex throughout the span of life. Neuroscientist (2004) 2.86
Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch Gen Psychiatry (1996) 2.76
Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder. Lancet (2003) 2.71
Causal heterogeneity in attention-deficit/hyperactivity disorder: do we need neuropsychologically impaired subtypes? Biol Psychiatry (2005) 2.70
D2R striatopallidal neurons inhibit both locomotor and drug reward processes. Nat Neurosci (2009) 2.65
The cortico-basal ganglia integrative network: the role of the thalamus. Brain Res Bull (2008) 2.49
Age-dependent decline of attention deficit hyperactivity disorder. Am J Psychiatry (1996) 2.05
A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia. Neuron (2010) 1.96
Waxholm Space atlas of the Sprague Dawley rat brain. Neuroimage (2014) 1.88
Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine. Neuropsychiatr Dis Treat (2010) 1.81
Basal ganglia volume and shape in children with attention deficit hyperactivity disorder. Am J Psychiatry (2008) 1.79
Imaging brain development: the adolescent brain. Neuroimage (2011) 1.77
Trajectories of cerebral cortical development in childhood and adolescence and adult attention-deficit/hyperactivity disorder. Biol Psychiatry (2013) 1.73
Gray matter volume abnormalities in ADHD: voxel-based meta-analysis exploring the effects of age and stimulant medication. Am J Psychiatry (2011) 1.69
Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progress. Neuropsychopharmacology (2010) 1.62
Meta-analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects. Acta Psychiatr Scand (2011) 1.48
The spontaneously hypertensive rat model of ADHD--the importance of selecting the appropriate reference strain. Neuropharmacology (2009) 1.48
Cingulate, frontal, and parietal cortical dysfunction in attention-deficit/hyperactivity disorder. Biol Psychiatry (2011) 1.47
Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder. J Clin Psychopharmacol (2008) 1.44
Thinner Medial Temporal Cortex in Adolescents With Attention-Deficit/Hyperactivity Disorder and the Effects of Stimulants. J Am Acad Child Adolesc Psychiatry (2015) 1.44
Effects of stimulants on brain function in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Biol Psychiatry (2013) 1.40
A review of stimulant drug research with hyperactive children. J Child Psychol Psychiatry (1977) 1.35
The Brain on Drugs: From Reward to Addiction. Cell (2015) 1.23
Volumetric MRI differences in treatment-naïve vs chronically treated children with ADHD. Neurology (2006) 1.21
Mapping the development of the basal ganglia in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2014) 1.12
Heterogeneity in ADHD: neuropsychological pathways, comorbidity and symptom domains. J Abnorm Child Psychol (2009) 1.11
Basal ganglia surface morphology and the effects of stimulant medications in youth with attention deficit hyperactivity disorder. Am J Psychiatry (2010) 1.08
Methylphenidate administration to juvenile rats alters brain areas involved in cognition, motivated behaviors, appetite, and stress. J Neurosci (2007) 1.08
The organization of the descending ventral pallidal projections in the monkey. J Comp Neurol (1993) 1.05
Characterizing anatomic differences in boys with attention-deficit/hyperactivity disorder with the use of deformation-based morphometry. AJNR Am J Neuroradiol (2007) 1.00
Striatal circuits, habits, and implications for obsessive-compulsive disorder. Curr Opin Neurobiol (2014) 0.98
Methylphenidate reduces energy intake and dietary fat intake in adults: a mechanism of reduced reinforcing value of food? Am J Clin Nutr (2007) 0.97
Magnetic resonance imaging volumetric analysis of the putamen in children with ADHD: combined type versus control. J Atten Disord (2006) 0.93
Effect of psychostimulants on brain structure and function in ADHD: a qualitative literature review of magnetic resonance imaging-based neuroimaging studies. J Clin Psychiatry (2013) 0.91
Animal models to guide clinical drug development in ADHD: lost in translation? Br J Pharmacol (2011) 0.91
Neural Correlates of Aggression in Medication-Naive Children with ADHD: Multivariate Analysis of Morphometry and Tractography. Neuropsychopharmacology (2015) 0.87
Long-term oral methylphenidate treatment in adolescent and adult rats: differential effects on brain morphology and function. Neuropsychopharmacology (2013) 0.83
Preclinical pharmacokinetics, pharmacology and toxicology of lisdexamfetamine: a novel d-amphetamine pro-drug. Neuropharmacology (2014) 0.82
Comparison of magnetic resonance imaging in live vs. post mortem rat brains. PLoS One (2013) 0.82
Stimulant side effects and inverted-U: implications for ADHD guidelines. Aust N Z J Psychiatry (2012) 0.78
Alterations in amygdala-prefrontal circuits in infants exposed to prenatal maternal depression. Transl Psychiatry (2016) 0.75